Overview
- Glooko launched GestationalCare, a pregnancy-specific module for diabetes management.
- The solution helps care teams identify high-risk patients, review glucose patterns, support between-visit engagement, and manage postpartum transitions.
- It is available in the UK and is expected to launch in the US in October 2026.
The News
Glooko has expanded its ambulatory diabetes management platform with GestationalCare, designed to support patients with gestational diabetes, Type 1 diabetes, or Type 2 diabetes during pregnancy. The module brings glucose data, pregnancy-specific targets, risk signals, and patient context into a focused clinical workflow.
The platform helps care teams flag fasting and post-meal glucose highs, missing data, and other signals requiring attention while enabling secure patient engagement, education, and care requests between visits. It also supports continuity of care following delivery.
Industry Perspective
Diabetes management during pregnancy requires timely monitoring as glucose patterns and treatment needs can change rapidly. By consolidating data and engagement tools into one workflow, GestationalCare aims to reduce fragmented processes across multidisciplinary care teams.
Strategic Impact
The launch strengthens Glooko’s ambulatory platform by adding a specialized pregnancy-care workflow while extending its device connectivity, patient engagement, and clinical data capabilities to a time-sensitive area of diabetes care.
Source: Businesswire
